Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Doxercalciferol and Paricalcitol in CKD on Hemodialysis
NCT00454350Phase 4Completed
- Sponsor
- Sanofi
- Start
- Feb 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of doxercalciferol in secondary hyperparathyroidism (SHPT), sponsored by Sanofi. Started Feb 2007; status: completed.
02
Drugs
doxercalciferol
03
Conditions
secondary hyperparathyroidism (SHPT)
Beyond the preview
Go deeper on NCT00454350.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00454350.